• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成硝呋太尔类似物的体外和体内杀变形虫活性。

In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs.

机构信息

Ministry of Fisheries and Livestock, Department of Veterinary Services, Mulungushi House, P.O. Box 50600, Ridgeway, Lusaka 15100, Zambia.

Unit for Environmental Science and Management, Faculty of Natural and Agricultural Sciences, North-West University, Potchefstroom 2531, South Africa.

出版信息

Molecules. 2021 Jun 2;26(11):3372. doi: 10.3390/molecules26113372.

DOI:10.3390/molecules26113372
PMID:34199682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8199755/
Abstract

African trypanosomes cause diseases in humans and livestock. Human African trypanosomiasis is caused by and . Animal trypanosomoses have major effects on livestock production and the economy in developing countries, with disease management depending mainly on chemotherapy. Moreover, only few drugs are available and these have adverse effects on patients, are costly, show poor accessibility, and parasites develop drug resistance to them. Therefore, novel trypanocidal drugs are urgently needed. Here, the effects of synthesized nitrofurantoin analogs were evaluated against six species/strains of animal and human trypanosomes, and the treatment efficacy of the selected compounds was assessed in vivo. Analogs and , containing 11- and 12-carbon aliphatic chains, respectively, showed the highest trypanocidal activity (IC < 0.34 µM) and the lowest cytotoxicity (IC > 246.02 µM) in vitro. Structure-activity relationship analysis suggested that the trypanocidal activity and cytotoxicity were related to the number of carbons in the aliphatic chain and electronegativity. In vivo experiments, involving oral treatment with nitrofurantoin, showed partial efficacy, whereas the selected analogs showed no treatment efficacy. These results indicate that nitrofurantoin analogs with high hydrophilicity are required for in vivo assessment to determine if they are promising leads for developing trypanocidal drugs.

摘要

非洲锥体虫会导致人类和家畜患病。人类非洲锥虫病是由 和 引起的。动物锥虫病对发展中国家的畜牧业生产和经济有重大影响,其疾病管理主要依赖化疗。此外,可用的药物很少,这些药物对患者有不良反应,成本高,可及性差,寄生虫对它们产生耐药性。因此,迫切需要新型杀锥虫药物。在这里,评估了合成的硝基呋喃妥因类似物对六种动物和人类锥体虫的作用,并用体内实验评估了所选化合物的治疗效果。含有 11 个和 12 个碳原子的脂肪链的类似物 和 表现出最高的杀锥虫活性(IC < 0.34 µM)和最低的细胞毒性(IC > 246.02 µM)。构效关系分析表明,杀锥虫活性和细胞毒性与脂肪链中的碳原子数和电负性有关。体内实验涉及用硝基呋喃妥因进行口服治疗,显示出部分疗效,而所选类似物则没有治疗效果。这些结果表明,需要具有高亲水性的硝基呋喃妥因类似物进行体内评估,以确定它们是否是开发杀锥虫药物的有前途的先导化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463d/8199755/6961cc611022/molecules-26-03372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463d/8199755/328ad5ea6f85/molecules-26-03372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463d/8199755/6961cc611022/molecules-26-03372-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463d/8199755/328ad5ea6f85/molecules-26-03372-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/463d/8199755/6961cc611022/molecules-26-03372-g002.jpg

相似文献

1
In Vitro and In Vivo Trypanocidal Efficacy of Synthesized Nitrofurantoin Analogs.合成硝呋太尔类似物的体外和体内杀变形虫活性。
Molecules. 2021 Jun 2;26(11):3372. doi: 10.3390/molecules26113372.
2
Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.DB829 的药代动力学、冈比亚锥虫疗效和药物作用时间,一种用于治疗第二期人类非洲锥虫病的临床前候选药物。
Antimicrob Agents Chemother. 2013 Nov;57(11):5330-43. doi: 10.1128/AAC.00398-13. Epub 2013 Aug 19.
3
Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.新型喹诺酮类化合物的合成及抗布氏锥虫活性关系研究。
J Med Chem. 2012 Mar 22;55(6):2538-48. doi: 10.1021/jm101439s. Epub 2012 Mar 12.
4
In vitro anti-trypanosomal activity of synthetic nitrofurantoin-triazole hybrids against Trypanosoma species causing human African trypanosomosis.体外抗三氮唑硝呋太尔杂合体对引起人类非洲锥虫病的锥虫物种的活性。
Fundam Clin Pharmacol. 2024 Feb;38(1):72-83. doi: 10.1111/fcp.12940. Epub 2023 Jul 21.
5
New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.非洲昏睡病二期的新治疗选择:DB289氮杂类似物的体外和体内疗效
Antimicrob Agents Chemother. 2009 Oct;53(10):4185-92. doi: 10.1128/AAC.00225-09. Epub 2009 Jul 20.
6
Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.毛叶苦味菊内酯:首个具有体内抗布氏锥虫活性的植物天然产物。
Planta Med. 2012 Apr;78(6):553-6. doi: 10.1055/s-0031-1298241. Epub 2012 Feb 13.
7
In vitro and in vivo activities of 2-aminopyrazines and 2-aminopyridines in experimental models of human African trypanosomiasis.在人体非洲锥虫病实验模型中 2-氨基吡嗪和 2-氨基吡啶的体外和体内活性。
Antimicrob Agents Chemother. 2013 Feb;57(2):1012-8. doi: 10.1128/AAC.01870-12. Epub 2012 Dec 17.
8
In vitro antitrypanosomal activity of synthesized nitrofurantoin-triazole hybrids against Trypanosoma species causing animal African trypanosomosis.合成的硝呋太尔-三唑杂合体对引起动物非洲锥虫病的锥虫属的体外抗锥虫活性。
Exp Parasitol. 2024 Apr;259:108711. doi: 10.1016/j.exppara.2024.108711. Epub 2024 Feb 12.
9
Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.一系列具有抗锥虫寄生虫活性的三聚氰胺基硝基杂环化合物的设计与合成。
J Med Chem. 2005 Aug 25;48(17):5570-9. doi: 10.1021/jm050177+.
10
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.用于治疗人类非洲锥虫病的FTY720的鉴定与特性研究
Antimicrob Agents Chemother. 2015 Dec 14;60(3):1859-61. doi: 10.1128/AAC.02116-15.

引用本文的文献

1
Looking for approved-medicines to be repositioned as anti-Trypanosoma cruzi agents. Identification of new chemotypes with good individual- or in combination-biological behaviours.寻找可重新定位为抗克氏锥虫药物的已批准药物。鉴定具有良好个体或联合生物学行为的新化学类型。
Mem Inst Oswaldo Cruz. 2025 Feb 7;120:e240183. doi: 10.1590/0074-02760240183. eCollection 2025.
2
and Trypanocidal Efficacy of Nitrofuryl- and Nitrothienylazines.硝基呋喃嗪类和硝基噻吩嗪类化合物的杀锥虫效力
ACS Omega. 2023 Oct 31;8(45):43088-43098. doi: 10.1021/acsomega.3c06508. eCollection 2023 Nov 14.
3
In vitro trypanocidal activities and structure-activity relationships of ciprofloxacin analogs.

本文引用的文献

1
Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues.新型呋喃妥因类似物的一步合成及体外抗分枝杆菌活性。
Bioorg Chem. 2020 Mar;96:103587. doi: 10.1016/j.bioorg.2020.103587. Epub 2020 Jan 16.
2
Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.研究N'-[(5-硝基呋喃-2-基)亚甲基]取代酰肼对克氏锥虫的构效关系以设计新型活性化合物。
Eur J Med Chem. 2018 Jan 20;144:29-40. doi: 10.1016/j.ejmech.2017.12.011. Epub 2017 Dec 5.
3
Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
环丙沙星类似物的体外杀锥虫活性和构效关系。
Mol Divers. 2024 Aug;28(4):2667-2680. doi: 10.1007/s11030-023-10704-9. Epub 2023 Jul 23.
4
Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates.进一步研究硝异噻唑类化合物作为潜在的抗锥虫药物候选物。
Biomolecules. 2023 Apr 1;13(4):637. doi: 10.3390/biom13040637.
5
Evaluation of mono and combined nitrofurantoin therapy for toxoplasmosis using murine model.评价应用于弓形虫病的单药和联合硝呋太尔治疗的鼠模型研究。
Pathog Glob Health. 2023 Oct;117(7):664-673. doi: 10.1080/20477724.2023.2200577. Epub 2023 Apr 9.
6
Therapeutic Efficacy of Orally Administered Nitrofurantoin against Animal African Trypanosomosis Caused by Infection.口服呋喃妥因对感染所致动物非洲锥虫病的治疗效果
Pathogens. 2022 Mar 9;11(3):331. doi: 10.3390/pathogens11030331.
7
Molecular Basis of Interactions between the Antibiotic Nitrofurantoin and Human Serum Albumin: A Mechanism for the Rapid Drug Blood Transportation.抗生素硝呋太尔与人血清白蛋白相互作用的分子基础:快速药物血液转运的机制。
Int J Mol Sci. 2021 Aug 14;22(16):8740. doi: 10.3390/ijms22168740.
口服非昔硝唑治疗晚期非洲冈比亚锥虫布氏锥虫病:一项关键性多中心、随机、非劣效性试验。
Lancet. 2018 Jan 13;391(10116):144-154. doi: 10.1016/S0140-6736(17)32758-7. Epub 2017 Nov 4.
4
Marine-Derived Penicillium Species as Producers of Cytotoxic Metabolites.海洋来源的青霉属物种作为细胞毒性代谢产物的生产者。
Mar Drugs. 2017 Oct 24;15(10):329. doi: 10.3390/md15100329.
5
Estimating the economic and social consequences for patients diagnosed with human African trypanosomiasis in Muchinga, Lusaka and Eastern Provinces of Zambia (2004-2014).估计赞比亚穆钦加省、卢萨卡省和东部省被诊断患有非洲人类锥虫病的患者的经济和社会后果(2004 - 2014年)。
Infect Dis Poverty. 2017 Oct 10;6(1):150. doi: 10.1186/s40249-017-0363-6.
6
Human African trypanosomiasis.非洲人类锥虫病。
Lancet. 2017 Nov 25;390(10110):2397-2409. doi: 10.1016/S0140-6736(17)31510-6. Epub 2017 Jun 30.
7
The establishment of in vitro culture and drug screening systems for a newly isolated strain of Trypanosoma equiperdum.马媾疫锥虫新分离株体外培养及药物筛选系统的建立。
Int J Parasitol Drugs Drug Resist. 2017 Aug;7(2):200-205. doi: 10.1016/j.ijpddr.2017.04.002. Epub 2017 Apr 13.
8
The animal trypanosomiases and their chemotherapy: a review.动物锥虫病及其化学疗法:综述
Parasitology. 2016 Dec;143(14):1862-1889. doi: 10.1017/S0031182016001268. Epub 2016 Oct 10.
9
Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.锥虫硫醇和谷胱甘肽还原酶中杀锥虫芳氧基醌的结构分析与分子对接:与生化数据的比较
J Biomol Struct Dyn. 2017 Jun;35(8):1785-1803. doi: 10.1080/07391102.2016.1195283. Epub 2016 Jul 15.
10
Animal African Trypanosomiasis: Time to Increase Focus on Clinically Relevant Parasite and Host Species.动物非洲锥虫病:是时候关注具有临床相关性的寄生虫和宿主物种了。
Trends Parasitol. 2016 Aug;32(8):599-607. doi: 10.1016/j.pt.2016.04.012. Epub 2016 May 8.